Jakarta, December 9th 2025 – AstraZeneca Indonesia, a global science-led biopharmaceutical company, has once again earned the Best Place to Work 2025 certification—marking its fourth consecutive year of recognition by the Best Places to Work (BPTW) program. This achievement underscores the company’s unwavering commitment to fostering an inclusive and equitable workplace where every individual feels appreciated, supported, and empowered to grow.
As an organization driving the future of healthcare through science and innovation, AstraZeneca Indonesia continues to nurture a progressive, collaborative, and empowering work culture. This commitment is reflected in its strong performance across key assessment indicators, including corporate culture, career development opportunities, leadership, gender equality, and talent management—affirming AstraZeneca’s position as an employer of choice in Indonesia.
The global Best Places to Work certification program offers an objective evaluation framework that measures employee engagement and satisfaction, while recognizing organizations that consistently deliver high-quality workplace experiences and uphold the highest standards of working conditions.
President Director of AstraZeneca Indonesia, Esra Erkomay, stated, “We are honored to once again be named a Best Place to Work, marking our fourth consecutive year receiving this certification. This recognition reflects our steadfast commitment to creating a workplace where every individual feels valued, included, and empowered to succeed. At AstraZeneca, we believe that when our people thrive, science and innovation thrive—enabling us to deliver life-changing medicines to patients across Indonesia.”
Esra continued, “We are committed to advancing this progress by further promoting gender equality and strengthening inclusion at every level, ensuring balanced representation of men and women in leadership roles. These advancements reinforce our belief that diverse perspectives fuel collaboration, spark innovation, and drive sustainable impact. We will continue to cultivate a culture built on trust, belonging, and growth—so every AstraZeneca Indonesia employee can reach their full potential, contribute with purpose, and help shape a healthier future.”
To achieve this certification, AstraZeneca has consistently invested in talent development through a variety of training and leadership initiatives. These include Leadership Training & Workshops for managers, mentoring programs, and extensive capability-building and skills-development activities.
The company also upholds policies that support work–life balance, including flexible Work from Home (WFH) arrangements and a range of wellness programs that promote both physical and mental well-being. These initiatives ensure employees can develop personally and professionally within a positive, inclusive work environment.
AstraZeneca Indonesia’s strength lies in its dedicated employees, united in their mission to deliver meaningful innovation. By integrating science, purpose, and cross-stakeholder collaboration, AstraZeneca provides solutions that not only treat disease but also enhance quality of life. Guided by a commitment to push boundaries, the company continues to pursue healthcare breakthroughs that create tangible impact for patients and communities across Indonesia.
###
About AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company dedicated to discovering, developing, and commercializing prescription medicines across Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, as well as Respiratory & Immunology. Headquartered in Cambridge, UK, AstraZeneca operates in more than 100 countries, with its innovative therapies benefiting millions of patients worldwide. For further information, please visit www.astrazeneca.com or follow @AstraZeneca on social media.
